Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, whereas semaglutide activates only the GLP-1 receptor and tirzepatide activates GLP-1 and GIP receptors
Biochemical characterization of dithiol glutaredoxin 8 from Saccharomyces cerevisiae: the catalytic redox mechanism redux
Comparative Long-Term Outlook Neither Retatrutide nor Survodutide has long-term data beyond their Phase 2 and early Phase 3 trial durations
Your provider at Viata will help determine the safest, most effective plan during your consultation
US$ 22.61
US$ 21.80
US$ 21.29
US$ 22.37
